SATT Ile-de-France

SATT Ile-de-France
Name	SATT Ile-de-France
Formation	2012
Headquarters	Paris
Region served	Île-de-France
Leader title	CEO

SATT Ile-de-France

SATT Ile-de-France is a French technology transfer and innovation company created to accelerate the valorization of research from public institutions in the Île-de-France region. It operates at the interface between universities, public research organizations and industry, engaging with actors such as Université Paris-Saclay, CNRS, Inserm, CEA and Université Sorbonne Paris Nord to bridge laboratory results and market-ready technologies. The company collaborates with industrial partners including Sanofi, Dassault Systèmes, Thales Group and TotalEnergies while interacting with public funders like BPI France and regional authorities such as Conseil régional d'Île-de-France.

History

SATT Ile-de-France was established in the context of French innovation policy reforms influenced by initiatives at Ministry of Higher Education, Research and Innovation (France), the Investissements d’Avenir program and models from Boston University, Stanford University, Imperial College London, and Fraunhofer Society. The foundation process involved negotiations among higher education institutions including Université Paris 1 Panthéon-Sorbonne, Université Paris Diderot, PSL University and research organizations such as INRAE and CNRS. Early milestones included technology auditing campaigns modeled on practices from University of Cambridge, licensing negotiations with firms like Sanofi and spin-off creations inspired by success stories from Oxford University Innovation and Y Combinator. Over time, SATT Ile-de-France aligned with national players such as ANR and regional initiatives linked to Métropole du Grand Paris.

Mission and Activities

The mission centers on translational missions comparable to those of Technology Transfer Offices at Massachusetts Institute of Technology, combining patent strategy akin to European Patent Office practices with startup incubation resembling Station F and Ecole 42 acceleration. Core activities include intellectual property management drawing on norms from Organisation for Economic Co-operation and Development, licensing arrangements following templates from World Intellectual Property Organization, and seed investment practices similar to Seedcamp and Kima Ventures. It supports biomedical projects interfacing with Inserm, materials and engineering projects interacting with CEA and digital innovations linked to INRIA and CNRS research teams. The organization engages with legal frameworks such as Code de la propriété intellectuelle and European instruments including Horizon Europe.

Structure and Governance

The governance model reflects a board combining representatives from universities like Université Paris-Saclay, research agencies such as CNRS, and corporate stakeholders including Sanofi and Schneider Electric. Executive leadership follows corporate governance norms comparable to Société Anonyme statutes and includes technical advisory boards with experts from CEA, Inserm and INRIA. Operational units replicate functional divisions found at Imperial Innovations and Cambridge Enterprise, encompassing patenting teams, business development units, and incubation managers. Strategic oversight coordinates with regional entities such as Conseil régional d'Île-de-France and national funders like BPI France and ANR.

Funding and Partnerships

Funding sources include public instruments from Investissements d’Avenir, grants from Agence Nationale de la Recherche (ANR), equity investments alongside BPI France and co-investment arrangements with corporate partners like Sanofi, Thales Group and TotalEnergies. Partnerships span academic institutions such as Université Paris 1 Panthéon-Sorbonne, PSL University, Université Paris Diderot and research organizations including CNRS, Inserm, INRAE and CEA. Collaborative frameworks draw on models from European Institute of Innovation and Technology and cross-border arrangements similar to those between Adeunis and EIT Health. International linkages involve networks like EEN (Enterprise Europe Network) and benchmarks against Fraunhofer Society and Max Planck Society practices.

Notable Projects and Technology Transfers

Notable tech transfers encompass biomedical patents licensed to firms in the vein of Sanofi collaborations, software and AI technologies spun out to startups mirroring deals with Dassault Systèmes and Atos, and materials innovations transferred to industrial partners like Schneider Electric and TotalEnergies. Spin-offs supported recall founders who studied at institutions such as Université Paris-Saclay and PSL University, and have followed growth paths similar to BlaBlaCar and Deezer landmark trajectories. Projects have engaged clinical networks associated with AP-HP and regulatory frameworks akin to procedures at Agence nationale de sécurité du médicament et des produits de santé.

Impact and Metrics

Impact assessment uses indicators comparable to those published by Association of University Technology Managers and metrics tracked by European Commission reports: number of patents filed referencing European Patent Office databases, licenses signed with firms like Sanofi and Thales Group, startup creation following models from Y Combinator demo practices, and follow-on funding comparable to rounds seen at Station F accelerators. Regional economic effects are evaluated alongside Conseil régional d'Île-de-France statistics, and societal impacts are monitored in collaboration with healthcare networks such as AP-HP and environmental research linked to INRAE.

Category:Technology transfer organizations in France